12 Popular Penny Stocks on Robinhood to Watch

Page 10 of 10

1. Gossamer Bio Inc. (NASDAQ:GOSS)

No of hedge fund holders: 35

Gossamer Bio Inc. (NASDAQ:GOSS) is a clinical-stage biopharmaceutical company dedicated to developing innovative treatments for pulmonary arterial hypertension (PAH).

The company remains focused on its lead asset, seralutinib, which is currently in Phase 3 registrational study for pulmonary arterial hypertension (PAH) with topline data expected in Q4 2025. Additionally, Gossamer Bio Inc. (NASDAQ:GOSS) is preparing to launch a Phase 3 trial for pulmonary hypertension associated with interstitial lung disease (PH-ILD) in the second half of 2025. The company also received an Orphan Drug Designation for the treatment of PAH in Japan, positioning it for potential global market expansion.

For the full year ended December 31, 2024, Gossamer Bio Inc. (NASDAQ:GOSS) reported a net loss of $56.5 million, or $0.25 per share, a significant improvement compared to the $179.8 million net loss, or $1.18 per share, in 2023. The company ended the year with $294.5 million in cash, cash equivalents, and marketable securities, which it expects will fund operations through the first half of 2027. Research and Development (R&D) expenses were $138.5 million, slightly higher than the previous year’s $135.3 million, reflecting ongoing investments in clinical trials.

Overall, Gossamer Bio Inc. (NASDAQ:GOSS) ranks first on our list of the 12 Popular Penny Stocks on Robinhood to Watch. While we acknowledge the potential for GOSS as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than GOSS but that trades at less than 5 times its earnings, check out our report about the cheapest AI stock.

READ NEXT: 20 Best AI Stocks To Buy Now and 30 Best Stocks to Buy Now According to Billionaires.

Disclosure: None. Insider Monkey focuses on uncovering the best investment ideas of hedge funds and insiders. Please subscribe to our free daily e-newsletter to get the latest investment ideas from hedge funds’ investor letters by entering your email address below.

Page 10 of 10